Cardinal Health Inc (CAH)
103.54
+0.17
(+0.16%)
USD |
NYSE |
Apr 24, 16:00
103.00
-0.54
(-0.52%)
Pre-Market: 20:00
Cardinal Health Enterprise Value: 25.32B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | 25.32B |
April 23, 2024 | 25.28B |
April 22, 2024 | 25.15B |
April 19, 2024 | 26.45B |
April 18, 2024 | 25.92B |
April 17, 2024 | 26.04B |
April 16, 2024 | 26.20B |
April 15, 2024 | 26.17B |
April 12, 2024 | 25.70B |
April 11, 2024 | 26.02B |
April 10, 2024 | 26.39B |
April 09, 2024 | 26.42B |
April 08, 2024 | 26.76B |
April 05, 2024 | 26.87B |
April 04, 2024 | 26.92B |
April 03, 2024 | 27.12B |
April 02, 2024 | 27.19B |
April 01, 2024 | 27.39B |
March 28, 2024 | 27.35B |
March 27, 2024 | 27.51B |
March 26, 2024 | 27.28B |
March 25, 2024 | 27.14B |
March 22, 2024 | 27.14B |
March 21, 2024 | 27.51B |
March 20, 2024 | 27.35B |
Date | Value |
---|---|
March 19, 2024 | 27.58B |
March 18, 2024 | 26.93B |
March 15, 2024 | 27.04B |
March 14, 2024 | 26.87B |
March 13, 2024 | 27.15B |
March 12, 2024 | 28.26B |
March 11, 2024 | 28.22B |
March 08, 2024 | 28.15B |
March 07, 2024 | 27.78B |
March 06, 2024 | 27.04B |
March 05, 2024 | 27.60B |
March 04, 2024 | 27.53B |
March 01, 2024 | 27.71B |
February 29, 2024 | 27.37B |
February 28, 2024 | 27.29B |
February 27, 2024 | 26.79B |
February 26, 2024 | 26.96B |
February 23, 2024 | 26.43B |
February 22, 2024 | 26.20B |
February 21, 2024 | 25.81B |
February 20, 2024 | 25.76B |
February 16, 2024 | 25.54B |
February 15, 2024 | 25.66B |
February 14, 2024 | 25.32B |
February 13, 2024 | 25.52B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.87B
Minimum
Jul 05 2022
28.26B
Maximum
Mar 12 2024
20.52B
Average
19.94B
Median
Mar 23 2021
Enterprise Value Benchmarks
McKesson Corp | 74.64B |
Cencora Inc | 49.52B |
Boston Scientific Corp | 115.45B |
DaVita Inc | 21.28B |
Elevance Health Inc | 114.85B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 353.00M |
Revenue (Quarterly) | 57.44B |
Total Expenses (Quarterly) | 56.94B |
EPS Diluted (Quarterly) | 1.43 |
Gross Profit Margin (Quarterly) | 3.21% |
Profit Margin (Quarterly) | 0.61% |
Earnings Yield | 2.45% |
Operating Earnings Yield | 7.76% |
Normalized Earnings Yield | 5.054 |